Skip to main content
. Author manuscript; available in PMC: 2022 Feb 12.
Published in final edited form as: Semin Thorac Cardiovasc Surg. 2017 May 30;29(3):391–405. doi: 10.1053/j.semtcvs.2017.05.012

Table 5.

Primary Care Physician Perceptions as Predictors for Lung Cancer Screening Practices

Survey Item and Response Options Ordered LDCT for Lung
Cancer Screening
Referred Patient to Lung Cancer
Screening Center for Screening
Initiated Discussion About Benefits and Risks
of Lung Cancer Screening With Patient
N (%) OR (95% CI) P N (%) OR (95% CI) P N (%) OR (95% CI) P
When a lung nodule is detected on CXR or CT, I feel confident managing the workup. Agree 133 (56.1) (Ref) 132 (56.2) (Ref) 131 (55.7) (Ref)
Disagree 71 (30.0) 1.04 (0.58-1.85) 0.90 69 (29.4) 0.95 (0.39-2.35) 0.91 71 (30.2) 0.88 (0.46-1.71) 0.72
Neutral 33 (13.9) 1.22 (0.57-2.64) 0.61 34 (14.5) 1.55 (0.56-4.33) 0.40 33 (14.0) 0.65 (0.28-1.48) 0.30
I prefer to self-manage lung nodule evaluation and follow-up rather than to refer to a specialist. Agree 51 (21.3) (Ref) 50 (21.1) (Ref) 51 (21.5) (Ref)
Disagree 145 (60.7) 0.52 (0.27-1.00) 0.052 143 (60.3) 0.66 (0.26-1.66) 0.38 143 (60.3) 0.72 (0.34-1.50) 0.37
Neutral 43 (18.0) 1.67 (0.70-3.99) 0.25 44 (18.6) 0.83 (0.26-2.61) 0.75 43 (18.1) 1.35 (0.49-3.67) 0.56

Ref, reference.

“Agree” includes all somewhat agree and strongly agree responses.

“Disagree” includes all somewhat disagree and strongly disagree responses.